JFL Life Sciences
JFLLIFE · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
0.0%
1w
9.6%
1m
9.1%
3m
10.4%
6m
11.4%
all
11.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 12 0%
10
15.4
Company Overview

Sales
80.1 Cr
Growth: 0.9%
Profit after Tax
4.82 Cr
Growth: 36.0%
Micro Cap
39.6 Cr
P/E: 8.2x
Industry P/E: 29.7x
Fundamentals

Sales (Cr) ₹ 80.1
Growth 0.9%
EBITDA 12.0%
P/S 0.5x
Dividend 0.0%
P/E 8.2x
Book Value ₹ 10
PEG Ratio 8.9x
ROE 14.6%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS). Major Events and Milestones2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
Belongs to (1 Indices)